Immunodiagnostics Market is estimated to be US$ 39.69 billion by 2030 with a CAGR of 7.50% during the forecast period


 Immunodiagnostics is a field of in vitro diagnostics that uses antigen antibody responses to diagnose disease. It is used to diagnose infectious infections as well as chronic diseases such as cancer and autoimmune disorders. It is used to treat cardiovascular diseases, infectious diseases, autoimmune disorders, endocrinology, and oncology, among other things. The human immune system is a complicated network of interconnected cells. Immunodiagnostics have advanced significantly, allowing for more accurate diagnosis of this complicated interacting network. The rise in the frequency and prevalence of infectious disorders (HIV, hepatitis, and other sexually transmitted infections), cardiovascular diseases, malignancies, and other chronic diseases has bolstered the immunodiagnostics industry. Furthermore, the expanding senior population, as well as changing lifestyle and demography, drive the market. The worldwide immunodiagnostics market is being driven by technological advancement and increased awareness.

Region Analysis:

Rise in demand for immunodiagnostics tests, increase in geriatric population, and the high incidence of chronic and infectious diseases, North America and Europe accounted for a substantial share of the worldwide immunodiagnostics market. Consumers are more likely to have frequent testing and check-ups as their understanding of early disease management grows. This, in turn, is expected to fuel the global market. During the forecast period, the Asia Pacific immunodiagnostics market is expected to grow at a substantial CAGR. Increased investment by several key companies in the region, increased awareness, advances in health care infrastructure, and favourable regulatory reforms boost the Asia Pacific immunodiagnostics market. Due to the availability of a huge population pool with significant clinical unmet demand, India and China are expected to drive the Asia Pacific immunodiagnostics market. This is expected to increase demand for immunodiagnostics. The market in Latin America and the Middle East and Africa is expected to grow during the forecast period, owing to increased investments from immunodiagnostics market participants and an increase in the prevalence of immunological illnesses in these regions.

Key Highlights:

  • Roche Diagnostics will launch the cobas SARS-CoV-2 Variant Set 1 Test in March 2021 to assist in the monitoring of developing coronavirus mutations.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4874

Key Market Insights from the report:

Global Immunodiagnostics Market accounted for US$ 19.30 billion in 2020 and is estimated to be US$ 39.69 billion by 2030 and is anticipated to register a CAGR of 7.50%.  The Global Immunodiagnostics Market report segments the market on the basis of type, technology, application and region.

  • Based on Type, Global Immunodiagnostics Market is segmented into Immunodiagnostic Instruments, Immunoassays.
  • Based on Technology, Global Immunodiagnostics Market is segmented into Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others. 
  • Based on Application, Global Immunodiagnostics Market is segmented into Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing, GI Stool Testing. 
  • By Region, the Global Immunodiagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Immunodiagnostics Market:

The key players operating in the Global Immunodiagnostics Market includes Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc.

Comments

Post a Comment

Popular posts from this blog

Osteoporosis Treatment Market is estimated to be US$ 17.68 billion by 2030 with a CAGR of 4.3% during the forecast period

Image
  The   Osteoporosis Treatment Market   accounted for US$ 11.60 billion in 2020 and is estimated to be US$ 17.68 billion by 2030 and is anticipated to register a CAGR of 4.3%. Osteoporosis is a condition in which body loses too much bone and there is an increase in bone weakness. The individual suffering from osteoporosis is more exposed to bone fractures. Hence, a proper treatment is required to cure and avoid the chances of complications. Osteoporosis, or thinning bones, can result in painful fractures. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications. The report “ Global Osteoporosis Treatment Market By Drugs Type (Selective Estrogen Receptor Modulators (SERMs), Rank Ligand (RANKL) Inhibitor, Calcitonin, Hormone Therapy, Parathyroid Hormone-Related Protein (PTHrP) Analog, and Bisphosphonates (Risedrona
Read more

Hand Sanitizers Market is estimated to be US$ 2.70 billion by 2030 with a CAGR of 7.50% during the forecast period

Image
  Hand Sanitizers Market  accounted for US$ 1.31 billion in 2020 and is estimated to be US$ 2.70 billion by 2030 and is anticipated to register a CAGR of 7.50%. Hand sanitizer is an antiseptic solution, also known as a hand disinfectant, hand antiseptic, hand rub. It is a liquid or gel containing alcohol use as an alternative to soap and water. It is used to clean the hands and kill infection-causing microorganisms. The main difference between washing hands with soap and hand sanitizer is soap work to remove all types of germs from hands, while sanitizer acts as killing germs present on the skin. It is an alcohol-based hand sanitizer work to reduce the number of germs but it is less effective in removing harmful chemicals, such as pesticides and heavy metals like lead. The report " Global Hand Sanitizers Market by Type (Gel, Foam, and Spray), By Application (Restaurant, Hospital, School, Household, and Office Building,), and By Region (North America, Europe, Asia Pacific, Latin Am
Read more

Sternal Closure Systems Market is estimated to be US$ 3.79 Billion by 2020 with a CAGR of 5.6% during the forecast period 2030

Image
  Sternal Closure Systems   Market  accounted for US$ 2.3 million in 2020 and is estimated to be US$ 3.79 billion by 2030 and is anticipated to register a CAGR of 5.6%.        The Sternal Closure Systems are used in bilateral thoracosternotomy, median sternotomy and hemisternotomy. Median sternotomy has become popular in early 1960s and remains gold standard approach in cardiac procedures. Sternal Closure Systems are used in stabilization and fixation of fractures at anterior part of chest wall. Change in lifestyle, lack of exercise and unhealthy diet has become common cause of cardiovascular diseases. Newly developed technology in medical field in metropolitan cities has given rise to heart surgeries which has boosts the Sternal Closure Systems Market. As cardiac surgeries had become routine surgery, it is determined that annually around one million heart surgeries are performed worldwide. Rate of coronary heart diseases are high in United States of America. According to data publishe
Read more